Cargando…

Impact of baseline blood pressure on all-cause mortality in patients with atrial fibrillation: results from a multicenter registry study

BACKGROUND: The ideal blood pressure (BP) target for patients with atrial fibrillation (AF) is still unclear. The present study aimed to assess the effect of the baseline BP on all-cause mortality in patients with AF. METHODS: This registry study included 20 emergency centers across China and consec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei, Song, Qirui, Zhang, Han, Wang, Juan, Shao, Xinghui, Wu, Shuang, Zhu, Jun, Cai, Jun, Yang, Yanmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129153/ https://www.ncbi.nlm.nih.gov/pubmed/36914952 http://dx.doi.org/10.1097/CM9.0000000000002627

Ejemplares similares

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Gender‐specific association between body mass index and all‐cause mortality in patients with atrial fibrillation
por: Lyu, Si‐qi, et al.
Publicado: (2020)

The Prognostic Effects of Ventricular Heart Rate Among Patients With Permanent Atrial Fibrillation With and Without Coronary Artery Disease: A Multicenter Prospective Observational Study
por: Wan, Huaibin, et al.
Publicado: (2015)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Clinical Characteristics and Impact of Diabetes Mellitus on Outcomes in Patients with Nonvalvular Atrial Fibrillation
por: Huang, Bi, et al.
Publicado: (2015)

Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation
por: Singh, Sheldon M., et al.
Publicado: (2020)

Increased mortality in patients with secondary diagnosis of atrial fibrillation: Report from Chinese AF registry
por: Shao, Xing‐Hui, et al.
Publicado: (2020)

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
por: Meinertz, Thomas, et al.
Publicado: (2011)

Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Chen, Ying, et al.
Publicado: (2015)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation
por: Chiang, Jiun-Yang, et al.
Publicado: (2020)

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
por: Buckley, Benjamin J. R., et al.
Publicado: (2021)

ASSOCIATION OF NEW ONSET ATRIAL FIBRILLATION WITH ALL-CAUSE MORTALITY IN COVID 19 PATIENTS.
por: Mansoor, Kanaan, et al.
Publicado: (2022)

Association of New-Onset Atrial Fibrillation With All-Cause Mortality in COVID-19 Patients
por: Zaheer, Kamran, et al.
Publicado: (2023)

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry
por: Apiyasawat, Sirin, et al.
Publicado: (2021)

Clinical characteristics and thrombotic risk of atrial fibrillation with obstructive sleep apnea: results from a multi-center atrial fibrillation registry study
por: Xu, Wei, et al.
Publicado: (2022)

Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry
por: Domínguez-Erquicia, Pablo, et al.
Publicado: (2021)

Association of chronic kidney disease with all-cause mortality in patients hospitalized for atrial fibrillation and impact of clinical and socioeconomic factors on this association
por: Bao, Min-qiang, et al.
Publicado: (2022)

Effects of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on one-year outcomes of patients with atrial fibrillation: insights from a multicenter registry study in China
por: LYU, Si-Qi, et al.
Publicado: (2020)

Red cell distribution width and all-cause mortality in patients with atrial fibrillation: A cohort study
por: Saliba, Walid, et al.
Publicado: (2017)

Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients
por: Vitolo, Marco, et al.
Publicado: (2023)

Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation
por: Chiou, Wei-Ru, et al.
Publicado: (2023)

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
por: Pokorney, Sean D., et al.
Publicado: (2016)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Design and Rationale of the National Tunisian Registry of Atrial Fibrillation: Protocol for a Prospective, Multicenter Trial
por: Ben Halima, Afef, et al.
Publicado: (2018)

Value of baseline characteristics in the risk prediction of atrial fibrillation
por: He, Jiacheng, et al.
Publicado: (2023)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis
por: Luo, Yanting, et al.
Publicado: (2021)

Prediction of all-cause mortality in coronary artery disease patients with atrial fibrillation based on machine learning models
por: Liu, Xinyun, et al.
Publicado: (2021)

Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

All-cause mortality trends in patients hospitalized for atrial fibrillation in Sweden: Role of age, stroke risk, and education
por: Sztaniszláv, Áron, et al.
Publicado: (2022)

The Neutrophil Percentage-to-Albumin Ratio is Associated with All-Cause Mortality in Patients with Atrial Fibrillation: A Retrospective Study
por: Xu, Yuxuan, et al.
Publicado: (2023)

Association of psychosocial factors with all‐cause hospitalizations in patients with atrial fibrillation
por: Meyre, Pascal B., et al.
Publicado: (2020)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Impact of the Fibrosis-4 Index on Risk Stratification of Cardiovascular Events and Mortality in Patients with Atrial Fibrillation: Findings from a Japanese Multicenter Registry
por: Saito, Yuki, et al.
Publicado: (2020)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
por: Sun, Yihong, et al.
Publicado: (2019)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model
por: Li, Jia, et al.
Publicado: (2021)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_trmautpmo009k5u96esjkbmkm5